SRZN Surrozen Inc.: רווח נקי למניה בארבעת הרבעונים האחרונים

Surrozen, Inc. (SRZN) adheres to strict environmental regulations regarding reagent disposal in its laboratories. The financial model relies on the reimbursement of regenerative liver and intestinal treatments through insurance funds. The current metric stands at -101.00. The diversity of developments in the Wnt pathway minimizes investment risks. The share price history below clearly illustrates the development dynamics of this biotech project.
SRZN (Surrozen Inc): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This indicator reflects the dynamics of net income per share over twelve months, allowing for an assessment of value generation efficiency and business resilience to market shocks. An analysis of the annual EPS TTM growth rate reveals a negative trend for Surrozen, Inc. (SRZN), which is expected for a biotech startup allocating all capital toward costly R&D in the absence of current sales.